293.61USD-0.57%Mkt Cap: 7.86B $P/E: 48.771d ago
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates throug…
Indicators:|
Key Statistics
Company
Market Cap7.86B $
Enterprise Value7.67B $
Revenue (TTM)2.59B $
Gross Profit1.34B $
Net Income (TTM)759.90M $
Revenue/Share95.80 USD
Last Price293.61 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS0905722072
Valuation
P/E (Trailing)48.77
P/E (Forward)30.20
PEG4.01
EV/EBITDA17.25
EV/Revenue2.96
P/S3.03
P/B1.15
EPS (TTM)6.02
EPS (Forward)9.72
52W Range
236.7353% of range343.12
52W High343.12 USD
52W Low236.73 USD
Profitability
Gross Margin51.87%
Oper. Margin5.76%
EBITDA Margin17.17%
Profit Margin29.42%
ROE10.20%
ROA7.18%
Growth
Revenue Growth1.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF532.20M $
CapEx (TTM)157.60M $
FCF Margin8.87%
FCF Yield2.92%
Net Debt-186.50M $
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity0.19
Current Ratio3.21
Quick Ratio2.19
Book Value/Sh255.37 USD
Cash/Share58.47 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateMar 8, 2002
Analyst Consensus
Rating—
Target (Mean)297.00 USD
Upside (mean)+1.2%
Target Range275.00 USD – 320.00 USD
$275.00+1.2% to mean$320.00
# Analysts5
Ownership
Shares Out.21.70M
Float20.91M
Insiders16.34%
Institutions94.38%
Short Interest
Short Ratio0.0d
Short % Float0.00%
Short % Out.0.00%
Shares Short1
Short (prev mo.)46
Technical
SMA 50283.43 (+3.6%)
SMA 200293.72 (-0.0%)
Beta1.08
S&P 52W Chg20.05%
Avg Vol (30d)345.36K
Avg Vol (10d)371.07K
Technical Indicators
RSI (14)53.2
MACD1.6263
MACD Signal1.4447
MACD Hist.+0.1816
BB Upper311.05 USD
BB Middle291.90 USD
BB Lower272.75 USD
BB Width13.12%
ATR (14)10.51 USD
Vol Ratio (20d)0.74x